Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury.

The development of vascular disease has its origins in an initial insult to the vessel wall by biological or mechanical factors. The disruption of homeostatic mechanisms leads to alteration of the original architecture of the vessel and its biological responsiveness, contributing to acute or chronic diseases such as stroke, hypertension, and atherosclerosis. Endothelial dysfunction, macrophage infiltration of the vessel wall, and proliferation and migration of smooth muscle cells all involve different types of reactive oxygen species produced by various vessel wall components. Although basic science and animal research have clearly established the role of reactive oxygen species in the progression of vascular disease, the failure of clinical trials with antioxidant compounds has underscored the need for better antioxidant therapies and a more thorough understanding of the role of reactive oxygen species in cardiovascular physiology and pathology.

[1]  J. Abe,et al.  Endothelial Atheroprotective and Anti‐inflammatory Mechanisms , 2001, Annals of the New York Academy of Sciences.

[2]  G. Dusting,et al.  Increased NADPH Oxidase Activity, gp91phox Expression, and Endothelium-Dependent Vasorelaxation During Neointima Formation in Rabbits , 2002, Circulation research.

[3]  L. Lazzarato,et al.  NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties. , 2006, Journal of medicinal chemistry.

[4]  C. Patterson,et al.  Catecholamine-Induced Vascular Wall Growth Is Dependent on Generation of Reactive Oxygen Species , 2004, Circulation research.

[5]  I-Chung Lo,et al.  Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. , 2005, Journal of biomedical science.

[6]  H. Conrad.  Extracellular Superoxide Dismutase , 1998 .

[7]  R. V. Sharma,et al.  eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[8]  S. Rosenkranz,et al.  Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. , 2006, Cardiovascular research.

[9]  D. Giddens,et al.  Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. , 2003, The Journal of biological chemistry.

[10]  M. Birrer,et al.  JunB Forms the Majority of the AP-1 Complex and Is a Target for Redox Regulation by Receptor Tyrosine Kinase and G Protein-coupled Receptor Agonists in Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.

[11]  E. Topol,et al.  Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials , 2003, The Lancet.

[12]  G. Gibbons,et al.  Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. , 1999, Circulation research.

[13]  G. Mcgregor,et al.  Rationale and impact of vitamin C in clinical nutrition , 2006, Current opinion in clinical nutrition and metabolic care.

[14]  H. Katus,et al.  Angiotensin II Stimulates Matrix Metalloproteinase Secretion in Human Vascular Smooth Muscle Cells via Nuclear Factor-κB and Activator Protein 1 in a Redox-Sensitive Manner , 2005, Journal of Vascular Research.

[15]  W. Parks,et al.  Hypochlorous Acid Oxygenates the Cysteine Switch Domain of Pro-matrilysin (MMP-7) , 2001, The Journal of Biological Chemistry.

[16]  R. Anderson,et al.  Pro-Oxidant Effect of Vitamin E in Cigarette Smokers Consuming a High Polyunsaturated Fat Diet , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[17]  H. Kaneto,et al.  Role of Pim-1 in Smooth Muscle Cell Proliferation* , 2004, Journal of Biological Chemistry.

[18]  V. Serebruany,et al.  The In Vitro Effects of a Novel Vascular Protectant, AGI-1067, on Platelet Aggregation and Major Receptor Expression in Subjects With Multiple Risk Factors for Vascular Disease , 2006, Journal of cardiovascular pharmacology and therapeutics.

[19]  C. Bode,et al.  Stimulation of a Vascular Smooth Muscle Cell NAD(P)H Oxidase by Thrombin , 1999, The Journal of Biological Chemistry.

[20]  D. Harrison,et al.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.

[21]  N. Wiernsperger,et al.  Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. , 2005, Diabetes.

[22]  Jason L. Johnson,et al.  Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Stocker,et al.  Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1 , 2004, Circulation.

[24]  C. Rice-Evans,et al.  Flavonoid antioxidants. , 2001, Current medicinal chemistry.

[25]  B. Berk,et al.  Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells. , 1995, Circulation research.

[26]  J. H. Lee,et al.  Leptin induces hypertrophy via p38 mitogen-activated protein kinase in rat vascular smooth muscle cells. , 2005, Biochemical and biophysical research communications.

[27]  Z. Galis,et al.  Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[28]  V. Tkachuk,et al.  Urokinase Plasminogen Activator Stimulates Vascular Smooth Muscle Cell Proliferation Via Redox-Dependent Pathways , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[29]  D. Harrison,et al.  Vascular Oxidant Stress Enhances Progression and Angiogenesis of Experimental Atheroma , 2004, Circulation.

[30]  J. Campolo,et al.  Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. , 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[31]  H. Griffiths,et al.  Vitamin C exhibits pro-oxidant properties , 1998, Nature.

[32]  Shokei Kim,et al.  Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. , 2003, Journal of pharmacological sciences.

[33]  S. Lee,et al.  Inhibition of rac1 reduces PDGF-induced reactive oxygen species and proliferation in vascular smooth muscle cells. , 2001, Journal of Korean medical science.

[34]  A. Struthers,et al.  Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure , 2002, Circulation.

[35]  P. Seshiah,et al.  Phosphoinositide-Dependent Kinase 1 and p21-Activated Protein Kinase Mediate Reactive Oxygen Species–Dependent Regulation of Platelet-Derived Growth Factor–Induced Smooth Muscle Cell Migration , 2004, Circulation research.

[36]  J. Keaney,et al.  Treatment of hypertension with ascorbic acid , 1999, The Lancet.

[37]  Manu O. Platt,et al.  Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Induces Monocyte Adhesion by Stimulating Reactive Oxygen Species Production From a Nox1-Based NADPH Oxidase , 2004, Circulation research.

[38]  Y. S. Kim,et al.  Sirolimus inhibits platelet-derived growth factor-induced collagen synthesis in rat vascular smooth muscle cells. , 2005, Transplantation proceedings.

[39]  Axel Haverich,et al.  Angiotensin II induces MMP-2 in a p47phox-dependent manner. , 2005, Biochemical and biophysical research communications.

[40]  David C. Lee,et al.  Transactivation of Epidermal Growth Factor Receptor Mediates Catecholamine-Induced Growth of Vascular Smooth Muscle , 2004, Circulation research.

[41]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[42]  S. Shyue,et al.  Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways. , 2004, Journal of molecular and cellular cardiology.

[43]  K. Kugiyama,et al.  Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[44]  Ju Yong Lee,et al.  Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro , 2001, Experimental & Molecular Medicine.

[45]  R Busse,et al.  Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. , 1996, Circulation.

[46]  J. Mehta,et al.  The Protective Effect of Superoxide Dismutase Mimetic M40401 on Balloon Injury-Related Neointima Formation: Role of the Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 , 2004, Journal of Pharmacology and Experimental Therapeutics.

[47]  Taylor Wr.  Hypertensive vascular disease and inflammation: mechanical and humoral mechanisms. , 1999 .

[48]  S. Signorelli,et al.  Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. , 2005, Clinical therapeutics.

[49]  Y. Castier,et al.  p47phox-Dependent NADPH Oxidase Regulates Flow-Induced Vascular Remodeling , 2005, Circulation research.

[50]  B L Langille,et al.  Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[51]  J. Wilcox,et al.  Upregulation of Nox‐Based NAD(P)H Oxidases in Restenosis After Carotid Injury , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[52]  N. Deshpande,et al.  Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. , 2002, Antioxidants & redox signaling.

[53]  W. R. Taylor,et al.  Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.

[54]  Keith K. Fenrich,et al.  Protection of Human Vascular Smooth Muscle Cells From H2O2-Induced Apoptosis Through Functional Codependence Between HO-1 and AKT , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[55]  J. Ouyang,et al.  N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression. , 2006, European journal of pharmacology.

[56]  A. Al Haj Zen,et al.  Adenovirus-Mediated Gene Transfer of Superoxide Dismutase and Catalase Decreases Restenosis after Balloon Angioplasty , 2005, Journal of Vascular Research.

[57]  K. Griendling,et al.  Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[58]  S. Azen,et al.  Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS) , 2002, Circulation.

[59]  A. Fisher,et al.  Selective role for superoxide in InsP3 receptor–mediated mitochondrial dysfunction and endothelial apoptosis , 2005, The Journal of cell biology.